miR-146a promotes the initiation and progression of melanoma by activating Notch signaling
Oncogenic mutations in BRAF and NRAS occur in 70% of melanomas. In this study, we identify a microRNA, miR-146a, that is highly upregulated by oncogenic BRAF and NRAS. Expression of miR-146a increases the ability of human melanoma cells to proliferate in culture and form tumors in mice, whereas knoc...
Main Authors: | Matteo Forloni, Shaillay Kumar Dogra, Yuying Dong, Darryl Conte Jr, Jianhong Ou, Lihua Julie Zhu, April Deng, Meera Mahalingam, Michael R Green, Narendra Wajapeyee |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2014-02-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/01460 |
Similar Items
-
Biomarkers for Diagnosis, Prognosis and Response to Immunotherapy in Melanoma
by: Rossella Puglisi, et al.
Published: (2021-06-01) -
Clinical mutational profiling and categorization of BRAF mutations in melanomas using next generation sequencing
by: Parvez M. Lokhandwala, et al.
Published: (2019-07-01) -
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach
by: Antonella Manca, et al.
Published: (2019-08-01) -
Evaluation of a Rapid, Fully Automated Platform for Detection of BRAF and NRAS Mutations in Melanoma
by: Fanny Barel, et al.
Published: (2017-09-01) -
Many Distinct Ways Lead to Drug Resistance in <i>BRAF</i>- and <i>NRAS</i>-Mutated Melanomas
by: Jiri Vachtenheim, et al.
Published: (2021-05-01)